Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease (NCT05908695) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 2023-08-31 |
| Long-term Efficacy and Safety Study of GV-971 (NCT05181475) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 2021-12-07 |
| A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) (NCT05058040) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 2021-06-02 |
| A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease (NCT04520412) | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 2020-10-27 |
Track Green Valley (Shanghai) Pharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.